Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
Status:
Completed
Trial end date:
2020-06-03
Target enrollment:
Participant gender:
Summary
A Phase 2, multicenter, double-blind, placebo control study evaluating the safety and
efficacy of Thykamine in adult patient suffering of mild-to-moderate Atopic Dermatitis